CDT Equity (CDT) Operating Expenses (2022 - 2026)
CDT Equity's (CDT) quarterly Operating Expenses came in at $3.0 million in Q2 2026, down 39.38% on a YoY basis from $5.0 million in Q2 2025, and down 17.89% quarter-over-quarter from $3.7 million in Q1 2026.
Analysis
CDT Equity (CDT) Operating Expenses (2022 - 2026) Analysis & Trends
CDT Equity (CDT) has reported Operating Expenses for 5 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Expenses fell 39.38% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2026 stood at $34.8 million (up 94.76% YoY), and the FY2025 full-year result was $36.8 million, up 138.39% from the prior year.
- Operating Expenses fell to $3.0 million in Q2 2026 per CDT's latest filing, from $3.7 million in the prior quarter.
- Across five years, Operating Expenses topped out at $21.2 million in Q4 2025 and bottomed at $243718.0 in Q1 2022.
- Historically, Operating Expenses has averaged $3.7 million across 5 years, with a median of $3.0 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses tumbled 53.91% in 2023, then surged 1251.4% in 2024.
- Over 5 years, Operating Expenses stood at $1.7 million in 2022, then soared by 45.1% to $2.4 million in 2023, then jumped by 44.63% to $3.5 million in 2024, then surged by 502.22% to $21.2 million in 2025, then sank by 85.81% to $3.0 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $3.0 million, $3.7 million, and $21.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.98 Bn | 621.22 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 446.60 Bn | 440.03 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 357.75 Bn | 350.61 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 267.43 Bn | 259.74 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Pfizer | 156.61 Bn | 144.91 Bn | 10.94 Bn | 6.68 Bn |
| 6 | Sanofi | 52.22 Bn | 44.84 Bn | 10.79 Bn | -5.98 Bn |
| 7 | Revolution Medicines | 42.95 Bn | 42.95 Bn | - | 505.13 Mn |
| 8 | Incyte | 24.57 Bn | 20.04 Bn | 1.57 Bn | 976.14 Mn |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | 452.50 Mn |
| 10 | CDT Equity | 182,285.66 | 182,285.66 | - | 3.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.00 Mn |
| Mar 31, 2026 | 3.66 Mn |
| Dec 31, 2025 | 21.16 Mn |
| Sep 30, 2025 | 7.03 Mn |
| Jun 30, 2025 | 4.95 Mn |
| Mar 31, 2025 | 3.62 Mn |
| Dec 31, 2024 | 3.51 Mn |
| Sep 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 3.14 Mn |
| Mar 31, 2024 | 2.96 Mn |
| Dec 31, 2023 | 2.43 Mn |
| Sep 30, 2023 | 430,000.00 |
| Jun 30, 2023 | 888,000.00 |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.67 Mn |
| Sep 30, 2022 | 933,000.00 |
| Jun 30, 2022 | 249,420.00 |
| Mar 31, 2022 | 243,718.00 |